Title | Type | SJR | H index | Total Docs. (2014) | Total Docs. (3years) | Total Refs. (2014) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2014) | %Female (2014) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
68 | BMC Clinical Pharmacology | journal | 0.883 Q2 | 43 | 0 | 37 | 0 | 113 | 37 | 3.29 | 0.00 | 0.00 | |
67 | BMC Pharmacology | journal | 0.968 Q2 | 48 | 0 | 22 | 0 | 59 | 22 | 4.00 | 0.00 | 0.00 | |
66 | HIV Clinical Trials | journal | 1.338 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
65 | Klinik Psikofarmakoloji Bulteni | journal | 0.165 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
64 | MeReC Bulletin | journal | 0.192 Q3 | 7 | 0 | 6 | 0 | 1 | 2 | 0.00 | 0.00 | 0.00 | |
63 | Therapy | journal | 0.159 Q3 | 22 | 0 | 73 | 0 | 24 | 66 | 0.00 | 0.00 | 0.00 | |
62 | Journal of Prescribing Practice | journal | 2 | 1 | 0 | 40 | 0 | 0 | 0.00 | 40.00 | 100.00 | ||
61 | Prescriber | journal | 4 | 1 | 0 | 22 | 0 | 0 | 0.00 | 22.00 | 100.00 | ||
60 | PharmacoEconomics - Italian Research Articles | journal | 0.111 Q4 | 9 | 2 | 46 | 91 | 1 | 37 | 0.00 | 45.50 | 20.00 | |
59 | Molecular Therapy - Oncolytics | journal | 42 | 6 | 0 | 290 | 0 | 0 | 0.00 | 48.33 | 44.83 | ||
58 | Therapeutic Advances in Respiratory Disease | journal | 0.974 Q2 | 50 | 20 | 99 | 763 | 270 | 93 | 2.42 | 38.15 | 28.13 | |
57 | Pharmaceutical Medicine | journal | 0.246 Q3 | 25 | 21 | 62 | 453 | 53 | 57 | 0.62 | 21.57 | 44.12 | |
56 | Therapeutic Advances in Drug Safety | journal | 0.360 Q3 | 46 | 21 | 70 | 1183 | 78 | 66 | 1.06 | 56.33 | 30.77 | |
55 | Therapeutic Advances in Cardiovascular Disease | journal | 0.686 Q2 | 41 | 24 | 76 | 1022 | 132 | 63 | 1.66 | 42.58 | 30.12 | |
54 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 46 | 27 | 73 | 1290 | 221 | 71 | 2.67 | 47.78 | 30.43 | ||
53 | HIV Research and Clinical Practice | journal | 54 | 28 | 109 | 895 | 343 | 106 | 3.18 | 31.96 | 53.31 | ||
52 | Antimicrobial Resistance and Infection Control | journal | 1.178 Q1 | 66 | 37 | 64 | 1046 | 233 | 54 | 3.64 | 28.27 | 42.68 | |
51 | AIDS Research and Therapy | journal | 0.924 Q2 | 49 | 39 | 113 | 1262 | 241 | 112 | 1.84 | 32.36 | 43.19 | |
50 | American Journal of Cardiovascular Drugs | journal | 0.992 Q2 | 60 | 40 | 133 | 2536 | 350 | 123 | 2.60 | 63.40 | 32.17 | |
49 | Expert Opinion on Emerging Drugs | journal | 0.982 Q2 | 54 | 41 | 129 | 3944 | 391 | 126 | 3.18 | 96.20 | 35.20 | |
48 | Cardiovascular Therapeutics | journal | 1.051 Q1 | 54 | 46 | 203 | 1736 | 552 | 194 | 2.75 | 37.74 | 23.66 | |
47 | Pharmaceutical Statistics | journal | 1.276 Q1 | 46 | 46 | 193 | 880 | 295 | 177 | 0.94 | 19.13 | 27.20 | |
46 | BioDrugs | journal | 0.875 Q2 | 79 | 48 | 146 | 2839 | 412 | 144 | 3.40 | 59.15 | 35.84 | |
45 | Biopharmaceutics and Drug Disposition | journal | 0.637 Q2 | 65 | 48 | 149 | 2036 | 418 | 143 | 2.73 | 42.42 | 29.06 | |
44 | Paediatric Drugs | journal | 0.777 Q2 | 70 | 49 | 134 | 3691 | 320 | 127 | 2.43 | 75.33 | 45.71 | |
43 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.061 Q1 | 57 | 56 | 168 | 3331 | 457 | 163 | 2.55 | 59.48 | 30.08 | |
42 | European Journal of Contraception and Reproductive Health Care | journal | 0.782 Q2 | 53 | 61 | 179 | 1332 | 322 | 170 | 1.55 | 21.84 | 55.76 | |
41 | Psychiatry and Clinical Psychopharmacology | journal | 24 | 63 | 167 | 1892 | 72 | 150 | 0.46 | 30.03 | 37.80 | ||
40 | Clinical Pharmacist | journal | 0.101 Q4 | 11 | 68 | 197 | 373 | 1 | 130 | 0.00 | 5.49 | 57.14 | |
39 | Drugs and Therapy Perspectives | journal | 0.105 Q4 | 13 | 71 | 214 | 1667 | 10 | 212 | 0.07 | 23.48 | 53.57 | |
38 | Human Psychopharmacology | journal | 0.818 Q2 | 86 | 72 | 245 | 3003 | 625 | 234 | 2.66 | 41.71 | 38.87 | |
37 | Fundamental and Clinical Pharmacology | journal | 0.700 Q2 | 85 | 73 | 242 | 3202 | 541 | 242 | 2.26 | 43.86 | 43.70 | |
36 | Journal of Chemotherapy | journal | 0.518 Q2 | 56 | 76 | 202 | 1953 | 334 | 170 | 1.79 | 25.70 | 39.43 | |
35 | BMC pharmacology & toxicology | journal | 0.715 Q2 | 43 | 77 | 83 | 2511 | 191 | 79 | 2.30 | 32.61 | 40.14 | |
34 | Clinical Practice | journal | 0.126 Q4 | 10 | 82 | 148 | 4462 | 25 | 124 | 0.17 | 54.41 | 36.52 | |
33 | Clinical Pharmacokinetics | journal | 1.928 Q1 | 184 | 83 | 195 | 5545 | 1171 | 189 | 5.73 | 66.81 | 38.58 | |
32 | Drugs and Aging | journal | 1.330 Q1 | 109 | 87 | 284 | 5042 | 998 | 264 | 3.58 | 57.95 | 41.41 | |
31 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.783 Q2 | 61 | 89 | 248 | 4509 | 532 | 233 | 1.97 | 50.66 | 37.50 | |
30 | Journal of Oncology Pharmacy Practice | journal | 0.418 Q3 | 44 | 94 | 196 | 2203 | 302 | 189 | 1.43 | 23.44 | 44.60 | |
29 | Clinical Drug Investigation | journal | 0.621 Q2 | 67 | 95 | 333 | 2594 | 698 | 317 | 2.00 | 27.31 | 35.83 | |
28 | CNS Drugs | journal | 1.922 Q1 | 129 | 95 | 255 | 8727 | 1477 | 236 | 5.79 | 91.86 | 40.23 | |
27 | Drug Safety | journal | 1.238 Q1 | 140 | 95 | 321 | 4352 | 1058 | 282 | 3.30 | 45.81 | 43.03 | |
26 | HIV Medicine | journal | 1.966 Q1 | 86 | 99 | 290 | 3537 | 1054 | 263 | 4.04 | 35.73 | 41.14 | |
25 | Expert Review of Clinical Pharmacology | journal | 0.870 Q2 | 60 | 100 | 218 | 6825 | 535 | 185 | 2.18 | 68.25 | 38.21 | |
24 | Journal of Biomedical Science | journal | 1.381 Q1 | 110 | 101 | 295 | 4558 | 1021 | 295 | 3.24 | 45.13 | 38.12 | |
23 | Antiviral Therapy | journal | 1.541 Q1 | 93 | 107 | 473 | 3662 | 1522 | 455 | 3.13 | 34.22 | 41.46 | |
22 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.738 Q2 | 81 | 111 | 318 | 3633 | 730 | 315 | 2.26 | 32.73 | 36.61 | |
21 | Expert Opinion on Orphan Drugs | journal | 0.191 Q3 | 27 | 130 | 100 | 8468 | 52 | 100 | 0.52 | 65.14 | 43.41 | |
20 | Journal of Psychopharmacology | journal | 1.659 Q1 | 135 | 134 | 471 | 7855 | 1966 | 446 | 4.35 | 58.62 | 36.41 | |
19 | Drug and Therapeutics Bulletin | journal | 0.147 Q3 | 17 | 138 | 418 | 901 | 37 | 95 | 0.09 | 6.53 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®